Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Schelling

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Hypertension|January 1, 1981
Immersion and venous occlusion plethysmography in patients with idiopathic orthostatic hypotensionP Jaeger, R Fawer, H R Brunner, et al.
Schweizerische Medizinische Wochenschrift|February 7, 1976
[Urinary mercury excretion in professional users of an antiseptic soap containing 0,04% phenylmercury borate]L Peters-Haefeli, J Michod, A Aellig, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Tolerability and pharmacokinetics of L-648,051. A leukotriene D4-receptor antagonist, in healthy volunteersJ Biollaz, E Stahl, J Y Hsieh, et al.
Bone|January 1, 1989
Influence of food and antacid administration on fluoride bioavailability from enteric-coated sodium fluoride tabletsP Arnold, M Wermeille, M C Chapuy, et al.
British Journal of Clinical Pharmacology|May 1, 1981
Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjectsD B Brunner, G Desponds, J Biollaz, et al.
British Journal of Clinical Pharmacology|December 15, 2004
Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. 1981D B Brunner, G Desponds, J Biollaz, et al.
Clinical Pharmacology and Therapeutics|June 1, 1991
Absence of metabolic effects of the topical carbonic anhydrase inhibitors MK-927 and sezolamide during two-week ocular administration to normal subjectsT Buclin, J Biollaz, E A Lippa, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1981
[Guidelines for the evaluation of the therapeutic effects of peripheral vasoactive drugs in arterial occlusive disease]K Adank, J P Barras, L Biland, et al.
British Journal of Clinical Pharmacology|September 1, 1982
Enalapril maleate and a lysine analogue (MK-521): disposition in manE H Ulm, M Hichens, H J Gomez, et al.
British Journal of Clinical Pharmacology|September 1, 1982
Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin systemJ Biollaz, J L Schelling, B Jacot Des Combes, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Hypertension|January 1, 1981
Immersion and venous occlusion plethysmography in patients with idiopathic orthostatic hypotensionP Jaeger, R Fawer, H R Brunner, et al.
Schweizerische Medizinische Wochenschrift|February 7, 1976
[Urinary mercury excretion in professional users of an antiseptic soap containing 0,04% phenylmercury borate]L Peters-Haefeli, J Michod, A Aellig, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Tolerability and pharmacokinetics of L-648,051. A leukotriene D4-receptor antagonist, in healthy volunteersJ Biollaz, E Stahl, J Y Hsieh, et al.
Bone|January 1, 1989
Influence of food and antacid administration on fluoride bioavailability from enteric-coated sodium fluoride tabletsP Arnold, M Wermeille, M C Chapuy, et al.
British Journal of Clinical Pharmacology|May 1, 1981
Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjectsD B Brunner, G Desponds, J Biollaz, et al.
British Journal of Clinical Pharmacology|December 15, 2004
Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. 1981D B Brunner, G Desponds, J Biollaz, et al.
Clinical Pharmacology and Therapeutics|June 1, 1991
Absence of metabolic effects of the topical carbonic anhydrase inhibitors MK-927 and sezolamide during two-week ocular administration to normal subjectsT Buclin, J Biollaz, E A Lippa, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1981
[Guidelines for the evaluation of the therapeutic effects of peripheral vasoactive drugs in arterial occlusive disease]K Adank, J P Barras, L Biland, et al.
British Journal of Clinical Pharmacology|September 1, 1982
Enalapril maleate and a lysine analogue (MK-521): disposition in manE H Ulm, M Hichens, H J Gomez, et al.
British Journal of Clinical Pharmacology|September 1, 1982
Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin systemJ Biollaz, J L Schelling, B Jacot Des Combes, et al.
Pageof 7